covaxin

Washington: More than 400 US colleges and universities have asked students since March to get COVID-19 vaccinations just ahead of the Autumn semester. But those who have been vaccinated…

Patna: Bharat Biotech has started paediatric trials of its COVID-19 vaccine Covaxin at the All India Institute of Medical Sciences (AIIMS) Patna. The Drugs Controller General of India…

New Delhi: Pulled up by Opposition and the judiciary for shortage of vaccines in the country, the Union government is going all out to ramp up COVID-19 vaccines so that the entire eligible…

Bhubaneswar: Amid the uncertainty over availability of vaccines for 18-44 age group, here's a good news for Odisha. The state is set to receive 26,000 doses of Covaxin by June 7 and…

New Delhi: Clinical trials of the third booster dose of COVID-19 vaccine Covaxin started at All India Institute of Medical Sciences, Delhi, on Monday. The trial will be conducted on 190…

New Delhi: There has been considerable debate over why the gap between doses of the Covishield vaccine has been changed since it was first used in India four months ago. As per the latest…

New Delhi: The Delhi High Court on Wednesday heard a PIL, to set aside the permission granted by the Drugs Controller General of India to Bharat Biotech for conducting the phase II/III…

Covaxin has been found to be effective against the B.1.617 and B.1.1.7 variants of COVID-19 which were first identified in India and the UK. Bharat Biotech, the manufacturer of Covaxin,…

New Delhi: The Drugs Controller General of India (DCGI) cleared Covaxin trials on children from two to 18 years on Thursday. This is the first time in India that a COVID-19 vaccine will be…

New Delhi: The current production capacity of Bharat Biotech-developed COVID-19 vaccine ‘Covaxin’ will be doubled by next month and increased nearly 6-7 folds by July-August 2021.…